Alaunos Therapeutics Ownership | Who Owns Alaunos Therapeutics?


OverviewForecastRevenueFinancialsChart

Alaunos Therapeutics Ownership Summary


Alaunos Therapeutics is owned by 1.45% institutional investors, 4.37% insiders, and 94.18% retail investors. Vanguard group is the largest institutional shareholder, holding 1.38% of TCRT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.56% of its assets in Alaunos Therapeutics shares.

TCRT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAlaunos Therapeutics1.45%4.37%94.18%
SectorHealthcare Stocks 232.51%10.72%-143.22%
IndustryBiotech Stocks 384.55%10.58%-295.13%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group30.06K1.38%$97.10K
Blackrock funding, inc. /de21.35K0.98%$68.97K
Geode capital management19.74K0.90%$63.76K
Hrt financial lp12.60K0.58%$40.00K
Tower research capital llc (trc)1.63K0.10%$3.94K
Morgan stanley1.65K0.08%$5.32K
Advisor group1.17K0.07%$2.81K
Ubs group1.31K0.06%$4.23K
Cibc private wealth group300.000.01%$969.00
Wells fargo & company/mn183.000.01%$441.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tower research capital llc (trc)1.63K0.00%$3.94K
Hrt financial lp12.60K0.00%$40.00K
Eversource wealth advisors---
Federation des caisses desjardins du quebec70.00-$226.00
Steward partners investment advisory92.00-$297.00
Barclays---
Thurston, springer, miller, herd & titak---
Advisor group1.17K-$2.81K
Truvestments capital---
Nbc securities20.00-$64.00

Top Buyers

HolderShares% AssetsChange
Hrt financial lp12.60K0.00%12.60K
Vanguard group30.06K-9.09K
Geode capital management19.74K-3.94K
Tower research capital llc (trc)1.63K0.00%660.00
Advisor group1.17K-470.00

Top Sellers

HolderShares% AssetsChange
Group one trading---300.00
Ubs group1.31K--224.00
Raymond james financial---99.00
Bokf, na---66.00
Barclays---50.00

New Positions

HolderShares% AssetsChangeValue
Hrt financial lp12.60K0.00%12.60K$40.00K
Citigroup89.00-89.00$287.00
Tidemark2.00-2.00$6.00
Tucker asset management1.00-1.00$3.00

Sold Out

HolderChange
Truvestments capital-1.00
Wealthspire advisors-1.00
Jpmorgan chase-3.00
Psi advisors-6.00
Investment management corp /va/ /adv-6.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20258-66.67%31,589-51.57%19.56%2-71.43%2-60.00%
Sep 30, 20255-80.77%21,173-70.16%16.43%1-83.33%--100.00%
Jun 30, 20256-76.92%21,065-70.09%16.80%1-83.33%--100.00%
Mar 31, 202526-10.34%70,434-2.20%421.75%6-25.00%5-58.33%
Dec 31, 2024293.57%72,017-62.50%43.13%860.00%12-47.83%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF24.91K1.56%-15.49K
Vanguard Total Stock Mkt Idx Inv17.35K1.08%-7.03K
Vanguard Institutional Extnd Mkt Idx Tr14.06K0.71%-6.41K
Fidelity Extended Market Index9.14K0.41%-64.00
BlackRock Extended Equity Market K2.98K0.19%-2.00
Extended Equity Market Fund K2.89K0.18%-58.00
Fidelity Series Total Market Index2.47K0.11%-1.57K
Fidelity Total Market Index2.38K0.11%-
NT Ext Equity Mkt Idx Fd - L1.36K0.08%-
Northern Trust Extended Eq Market Idx1.36K0.08%-

Recent Insider Transactions


DateNameRoleActivityValue
Jun 24, 2025Vieser Jaime-Buy$1.12K
Jun 24, 2025Postma Robert W-Buy$2.69K
Apr 11, 2025Postma Robert W-Buy$1.38K
Dec 31, 2024Vieser Jaime-Sell$4.39K
Dec 31, 2024Vieser Jaime-Sell$1.64K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q23-
2025 Q1--
2024 Q4-2
2024 Q3--

TCRT Ownership FAQ


Who Owns Alaunos Therapeutics?

Alaunos Therapeutics shareholders are primarily institutional investors at 1.45%, followed by 4.37% insiders and 94.18% retail investors. The average institutional ownership in Alaunos Therapeutics's industry, Biotech Stocks , is 384.55%, which Alaunos Therapeutics falls below.

Who owns the most shares of Alaunos Therapeutics?

Alaunos Therapeutics’s largest shareholders are Vanguard group (30.06K shares, 1.38%), Blackrock funding, inc. /de (21.35K shares, 0.98%), and Geode capital management (19.74K shares, 0.90%). Together, they hold 3.26% of Alaunos Therapeutics’s total shares outstanding.

Does Blackrock own Alaunos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Alaunos Therapeutics.

Who is Alaunos Therapeutics’s biggest shareholder by percentage of total assets invested?

Tower research capital llc (trc) is Alaunos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 1.63K Alaunos Therapeutics shares, valued at 3.94K$.

Who is the top mutual fund holder of Alaunos Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Alaunos Therapeutics shares, with 1.56% of its total shares outstanding invested in 24.91K Alaunos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools